Movement Imitation Therapy for Preterm Babies (MIT-PB): What influence does this early intervention have on the neuromotor development of preterm children with atypical spontaneous motor activity (General Movements)?
Descrizione riassuntiva dello studio
The Movement Imitation Therapy for Preterm Babies (MIT-PB) by Dr. Marina Soloveichick is a new treatment method for preterm infants that has been little studied so far. This study aims to find out whether the new treatment method has a greater positive influence on neuromotor development than conventional physiotherapy. To investigate this, there will be a control group and an intervention group, each with approximately 40 children. The children included in the study from the neonatology department of Inselspital Bern form the control group. The children included in the study from the neonatology clinic of USZ in Zurich form the intervention group. The children in the control group will be treated with conventional physiotherapy. Apart from documenting the frequency and contents of the treatments, nothing will change in the treatment. The children in the intervention group will be treated with conventional physiotherapy and additionally with MIT-PB. The parents will be introduced to the treatment so that they can carry out most of the treatment independently. They will be accompanied and supported by trained physiotherapists both in the hospital and after discharge. The treatment will be carried out until the age of 52 weeks (corrected three months). All children will undergo a test at 40 weeks, corrected three months, and two years to assess the child's neuromotor development status. Parents will be asked to complete a short self-efficacy questionnaire (PMP S-E) at the beginning of the study and at the three-month check-up. The total duration of the study per child is approximately 26 months.
(BASEC)
Intervento studiato
The children in the intervention group will be treated in addition to conventional physiotherapeutic treatment by the physiotherapist and/or by the parents with MIT-PB. The MIT-PB starts in neonatology and continues at home until the age of 52 weeks. Essential in this treatment method according to Dr. Marina Soloveichick is the manual redirection of atypical spontaneous movements towards as fluid and variable movements as possible. The child should be awake, content, and active during the treatment. The MIT-PB should be applied 5 times a day for 10 minutes.
(BASEC)
Malattie studiate
The neuromotor development of preterm children (under 32 weeks of gestation) with a high risk of mild to severe neuromotor developmental impairment.
(BASEC)
Children born before 32 weeks of gestation (in the neonatology clinic at USZ or the neonatology department of Inselspital Bern) and showing atypical General Movements (spontaneous movements) at 33-34 weeks of gestation and/or having a brain hemorrhage grade 3 or higher. (BASEC)
Criteri di esclusione
Comorbidities that could further restrict the motor behavior of preterm children (such as syndromic diseases, neuromuscular diseases, or diseases affecting the musculature and/or the skeletal system) (BASEC)
Luogo dello studio
Berna, Zurigo
(BASEC)
Sponsor
non disponibile
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
Stephanie Brezina
+41 44 255 92 78
ngn.mit-pb-studie@clutterusz.ch(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione etica Zurigo
(BASEC)
Data di approvazione del comitato etico
04.11.2022
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
non disponibile
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile